# A Pilot Study of High-Dose Omega-3 (Soloways ™) Polyunsaturated Fatty Acids in Patients with Dyslipidemia Carrying FADS1/FADS2 Variants

> **NCT06863935** · NA · COMPLETED · sponsor: **S.LAB (SOLOWAYS)** · enrollment: 40 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DIETARY_SUPPLEMENT:** High-dose omega-3 PUFA supplementation
- **DIETARY_SUPPLEMENT:** High-dose omega-3 PUFA supplementation

## Key facts

- **NCT ID:** NCT06863935
- **Lead sponsor:** S.LAB (SOLOWAYS)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-10
- **Primary completion:** 2024-09-19
- **Final completion:** 2025-01-18
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06863935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06863935, "A Pilot Study of High-Dose Omega-3 (Soloways ™) Polyunsaturated Fatty Acids in Patients with Dyslipidemia Carrying FADS1/FADS2 Variants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06863935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*